Oct. 25 at 2:51 PM
$DCTH My suppositions seems justified. Excerpt from Gemini:
pharmaceutical companies frequently fund studies, partner, or acquire companies involved in developing devices or advanced drug delivery mechanisms to enhance the outcomes of their drugs. This is a significant trend because better drug delivery can improve efficacy, reduce side effects, increase patient compliance (especially for chronic conditions), and potentially extend the life cycle of a successful drug.
The global market for advanced drug delivery systems is substantial and a key area of focus for the pharmaceutical industry, including in oncology